Skip to main content

Table 2 Group II, cases diagnosed with serous carcinoma

From: Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience

Case no.

HER2 amplification

Primary site

Histopathology diagnosis

IHC

FISH

Result

Type

FIGO

Nuc

1

0

2.75

POS

Ovary

SCA

3

3

2

0

2.26

POS

Endometrium

SCA

3

3

3

2+

5.16

POS

Endometrium

SCA

3

3

4

3+

6.1

POS

Endometrium

SCA

3

3

5

3+

NP

POS

Endometrium

SCA

3

3

6

0

1

NEG

Fallopian Tube

SCA

3

3

7

0

1

NEG

Ovary

SCA

3

3

8

0

1.03

NEG

Ovary

SCA

3

3

9

0

1.06

NEG

Ovary

SCA

3

3

10

0

1.4

NEG

Ovary

SCA

3

3

11

0

NP

NEG

Ovary

SCA

1

1

12

0

NP

NEG

Ovary

SCA

3

3

13

0

NP

NEG

Ovary

SCA

3

3

14

0

NP

NEG

Ovary

SCA

3

3

15

0

NP

NEG

Ovary

SCA

3

3

16

0

NP

NEG

Ovary

SCA

3

3

17

0

NP

NEG

Ovary

SCA

3

3

18

0

NP

NEG

Ovary

SCA

3

3

19

0

NP

NEG

Ovary

SCA

3

3

20

0

NP

NEG

Ovary

SCA

3

3

21

0

NP

NEG

Ovary

SCA

3

3

22

1+

1

NEG

Ovary

SCA

3

3

23

1+

1

NEG

Ovary

SCA

3

3

24

1+

1.2

NEG

Ovary

SCA

3

3

25

1+

NP

NEG

Ovary

SCA

3

3

26

1+

NP

NEG

Ovary

SCA

3

3

27

1+

NP

NEG

Ovary

SCA

3

3

28

1+

NP

NEG

Ovary

SCA

3

3

29

1+

NP

NEG

Ovary

SCA

3

3

30

1+

NP

NEG

Ovary

SCA

3

3

31

1+

NP

NEG

Ovary

SCA

3

3

32

1+

NP

NEG

Ovary

SCA

3

3

33

1+

NP

NEG

Ovary

SCA

3

3

34

1+

NP

NEG

Ovary

SCA

3

3

35

2+

1.62

NEG

Ovary

SCA

3

3

36

0

1.08

NEG

Peritoneum

SCA

3

3

37

0

NP

NEG

Peritoneum

SCA

3

3

38

0

NP

NEG

Peritoneum

SCA

3

3

39

1+

NP

NEG

Peritoneum

SCA

3

3

40

1+

NP

NEG

Peritoneum

SCA

3

3

41

1+

NP

NEG

Endometrium

SCA

3

3

42

1+

NP

NEG

Endometrium

SCA

3

3

43

1+

NP

NEG

Endometrium

SCA

3

3

44

2+

0.91

NEG

Endometrium

SCA

3

3

45

2+

1.21

NEG

Endometrium

SCA

3

3

  1. Bold data signify the positive results
  2. IHC immunohistochemistry score, FISH fluorescence in-situ hybridization HER2/CEP17 ratio, FIGO FIGO grade, Nuc nuclear grade, NP not performed, POS positive, NEG negative, SCA serous carcinoma